Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications

Clinical trial NCT02649790 · COMPLETED

Trial details

NCT number: NCT02649790
Sponsor: Karyopharm Therapeutics Inc
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed/Refractory Multiple Myeloma (RRMM)Metastatic Colorectal Cancer (mCRC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Higher-Risk Myelodysplastic Syndrome (HR-MDS)Acute Myeloid Leukemia (AML)Newly Diagnosed Intermediate/High-Risk MDS

Start date: 2016-01-01
Primary completion: 2024-08-31
Enrollment: 277

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.